Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Gains from Investment Securities: 2018-2025

Historic Gains from Investment Securities for Organogenesis Holdings (ORGO) over the last 8 years, with Sep 2025 value amounting to $573,000.

  • Organogenesis Holdings' Gains from Investment Securities rose 2022.22% to $573,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year increase of 271.01%. This contributed to the annual value of $10.6 million for FY2024, which is 13.10% up from last year.
  • Organogenesis Holdings' Gains from Investment Securities amounted to $573,000 in Q3 2025, which was up 2,915.79% from $19,000 recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Gains from Investment Securities registered a high of $28.4 million during Q2 2021, and its lowest value of -$5.1 million during Q3 2022.
  • For the 3-year period, Organogenesis Holdings' Gains from Investment Securities averaged around $1.4 million, with its median value being $885,000 (2023).
  • As far as peak fluctuations go, Organogenesis Holdings' Gains from Investment Securities surged by 4,597.02% in 2021, and later tumbled by 426.96% in 2022.
  • Organogenesis Holdings' Gains from Investment Securities (Quarterly) stood at $23.2 million in 2021, then slumped by 100.30% to -$70,000 in 2022, then spiked by 1,144.29% to $731,000 in 2023, then skyrocketed by 434.61% to $3.9 million in 2024, then soared by 2,022.22% to $573,000 in 2025.
  • Its last three reported values are $573,000 in Q3 2025, $19,000 for Q2 2025, and $1.8 million during Q1 2025.